Your browser doesn't support javascript.
loading
Oral and Palmitate Paliperidone Long-Acting Injectable Formulations' Use in Schizophrenia Spectrum Disorders: A Retrospective Cohort Study from the First Episode Psychosis Intervention Program (CRUPEP).
Segarra, R; Recio-Barbero, M; Sáenz-Herrero, M; Mentxaka, O; Cabezas-Garduño, J; Eguíluz, J I; Callado, L F.
Afiliación
  • Segarra R; Biocruces Bizkaia Health Research Institute, Cruces University Hospital, Bilbao, Spain.
  • Recio-Barbero M; Department of Psychiatry, Cruces University Hospital, Bilbao, Spain.
  • Sáenz-Herrero M; Department of Neurosciences, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), Leioa, Spain.
  • Mentxaka O; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Spain.
  • Cabezas-Garduño J; Biocruces Bizkaia Health Research Institute, Cruces University Hospital, Bilbao, Spain.
  • Eguíluz JI; Biocruces Bizkaia Health Research Institute, Cruces University Hospital, Bilbao, Spain.
  • Callado LF; Department of Psychiatry, Cruces University Hospital, Bilbao, Spain.
Int J Neuropsychopharmacol ; 24(9): 694-702, 2021 09 21.
Article en En | MEDLINE | ID: mdl-34009370

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Esquizofrenia / Antipsicóticos / Palmitato de Paliperidona Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Neuropsychopharmacol Asunto de la revista: NEUROLOGIA / PSICOFARMACOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trastornos Psicóticos / Esquizofrenia / Antipsicóticos / Palmitato de Paliperidona Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Neuropsychopharmacol Asunto de la revista: NEUROLOGIA / PSICOFARMACOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: España